Medivir AB published on April 11th, 2011 a press release with information about a public offer to the shareholders in BioPhausia AB (publ). The current rules of NASDAQ OMX Stockholm AB state that a listed company will be given an observation status if the company is subject to a public offer or if a bidder has disclosed its intention to raise such a bid in respect of the company.
With reference to what is stated above NASDAQ OMX Stockholm AB has decided that the shares in BioPhausia AB (publ) (BIOP, ISIN-code SE0001048984, order book-ID 960) will be given an observation status. The shares will be given an observation status with effect from today April 11th, 2011.
For further information concerning this exchange notice please contact Patrik Hellgren or Anna Jansson, telephone + 46 8 405 70 50.
